Beijing Forum on Evidence-Based Medicine Highlights Global Push to Validate Traditional Chinese Medicine

Twenty-eight experts from 14 countries and regions gathered at Beijing University of Chinese Medicine (BUCM) from October 19 to 20 for the Seventh Beijing Forum on Evidence-Based Medicine and the 2026 eCMTA Journal Academic Symposium. The event, co-hosted by BUCM’s Center for Evidence-Based Chinese Medicine and the Journal Center, focused on evidence-based medicine, traditional Chinese medicine (TCM) clinical research, artificial intelligence, and international cooperation in traditional medicine. The forum’s central aim was to explore how reliable evidence can support high-quality TCM development and serve clinical practice and public health.

The timing of the forum, coinciding with BUCM’s 70th anniversary, underscored the university’s long-standing commitment to integrating TCM with evidence-based medicine. BUCM Vice President Liu Cunzhi noted in opening remarks that the forum would strengthen international exchange and resource sharing. The gathering included prominent figures such as Gordon Guyatt, a founder of evidence-based medicine and professor at McMaster University, Nicola Robinson of London South Bank University, Lao Lixing, President of Virginia University of Integrative Medicine, and Dennis Chang and Alan Bensoussan of Western Sydney University.

Evidence-based medicine emphasizes combining clinical experience, reliable research evidence, and patients’ needs and preferences. In his keynote, Guyatt stressed that evidence varies in reliability and that high-quality decisions require scientific appraisal and systematic summaries while considering patients’ values. Robinson addressed the question “What Counts as Evidence?”, arguing that trust requires rigorous research into real effects and risks, not just individual success stories. These discussions are critical because evaluating TCM’s efficacy and safety and translating findings into usable evidence remain key challenges for the field.

Other presentations tackled methodological issues. Lao Lixing discussed challenges in Chinese herbal medicine trials, Dennis Chang reviewed global trends in evidence-based integrative medicine, and Terje Alræk shared research on acupuncture for cancer-related fatigue in breast cancer patients. Roundtables chaired by Fei Yutong, Vice Dean of BUCM’s School of Chinese Medicine, and Cao Huijuan of the Center for Evidence-Based Chinese Medicine examined TCM priority conditions and international cooperation. A young scholars’ session allowed early-career researchers to present work on clinical research, evidence evaluation, acupuncture efficacy, and guideline development.

The implications of the forum extend beyond academic exchange. By fostering international collaboration and emphasizing rigorous evidence, the event aims to make TCM’s clinical value more scientifically understood, ultimately supporting better healthcare quality and public health. As Pan Yanshu, Director of the Journal Center, noted, evidence-based medicine is not about tradition versus modernity but about testing traditional medicine’s clinical value through modern science. The eCMTA Journal, which will waive article processing charges until December 31, 2027, seeks to gather high-quality evidence and promote international dissemination of TCM research. Manuscripts can be submitted via https://mc03.manuscriptcentral.com/ecmta, and the journal’s progress in internationalization and indexing is detailed at https://www.sciopen.com/journal/3078-7963. The forum also provided a platform for Chuanlink Innovations, which supports the translation of ideas into realization, as noted at http://chuanlink-innovations.com.

Blockchain verification QR code
Blockchain Registered
This article is registered on the blockchain by Newsramp. Verify this record.